Skip to main content
OpenTrials
Completed

NCT Number: NCT03736200

Neuro-rehabilitation Training Effects on Motion and Quality of Life After Acute Stroke and Post Stroke

High intensity motion improves motor functions and quality of life in a neurologist. The investigators want to improve the clinical condition and quality of life of post-STROKE participants with a special sensory motor and visual motor agility therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

55 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

József Tollá

Kaposvár, Somogy County, 7400, Hungary

About this study

High intensity motion improves engine function and quality of life in a neurologist. With special sensory motor and visual motility, investigaters want to improve the clinical condition and quality of life of STROKE participants.

The investigaters randomly select participants who only perform the rehabilitation treatment have performed. The other group that will receive the study's control group will receive the traditional rehabilitation physiotherapy treatment.

The investigaters assess the condition and quality of life of the patients. (EQ5-D, Barthel index, MRS test) The ivestigaters examine the functional movement and equilibrium variables of patients. (6MWT, Berg balance test, postgraduation) After that, participants are undergoing a 4-week intensive rehabilitation treatment. All participants are in post stroke.

Primary Hypothesis will be changes in life-quality tests (EQ5-D, Barthel index, MRS test). Functional tests show progress 6MWT, Berg balance test and postural control testing with posturography. The results are compared and evaluated among the groups.

The expected hypothesis is that visual and acoustic stimulation produces a better physical state at higher intensity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • post stroke
  • 6MWT : 120>
  • minimum after stroke 2 weeks

Exclusion criteria

  • Sever heart problem
  • sever demeanor
  • alcoholism
  • drug problems

Treatment and study plan

Exergaming group

Other

Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (1/day)

Other names: EXE group

Physiotherapy

Other

Physiotherapy 4-week-long.

Other names: Physio group

Exergaming group 2/day

Other

Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (2/day)

Other names: EXE2 group

Primary outcomes

  1. Quality of life measured by Barthel index

    Time frame: 4 weeks

    questionnaire

  2. gait / functional test

    Time frame: 4 weeks

    6 minute walk test (m)

  3. balance test

    Time frame: 4 weeks

    Berg balance test

  4. postrural control test

    Time frame: 4 weeks

    posturography (mm)

  5. Quality of life measured by EQ5-D scale

    Time frame: 4 weeks

    questionnaire

Sponsors and collaborators

Lead sponsor

Somogy Megyei Kaposi Mór Teaching Hospital

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Nov 9, 2018
Registry last updated
Apr 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.